by South Australian Health and Medical Research Institute (SAHMRI) Schematic of orally-delivered EcN probiotic engineered to lyse and produce immunotherapeutic proteins in situ (top) and schematic of dosing regimen (bottom). Credit: Nature Communications (2024). DOI: 10.1038/s41467-024-44776-4An international team of researchers from Adelaide and the United States has opened the door to non-stool-based bowel cancer detection...
